Evidence map›Paper›PMID 38275072›Full record

ReviewRecent patents on biotechnology2025

Medicinal Plants in the Treatment of Respiratory Diseases and their Future Aspects.

Aliya Firdaus, Mohd Hadi Yunus, Syed Khalida Izhar, Uzma Afaq

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent patents on biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Plants (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Phytochemical Analysis and Antimicrobial Potential ofRecent patents on biotechnology · 2025
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aliya FirdausBiocontrol Research Laboratory, Integral Information and Research Centre-4 (IIRC-4), Integral University, Lucknow, UP-226026, India.
Mohd Hadi YunusDepartment of Biotechnology, Jamia Hamdard University, New Delhi, India.
Syed Khalida IzharBiocontrol Research Laboratory, Integral Information and Research Centre-4 (IIRC-4), Integral University, Lucknow, UP-226026, India.
Uzma AfaqBiocontrol Research Laboratory, Integral Information and Research Centre-4 (IIRC-4), Integral University, Lucknow, UP-226026, India.
Integral University · INDepartment of Biotechnology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The utilization of medicinal plants in the treatment of respiratory diseases has a rich history dating back centuries. A vast body of research literature, including review articles, research papers, case studies, patents, and books, provides substantial evidence supporting the use of medicinal plants in the treatment of diseases and injuries. This study delves into the diverse range of plant species known for their therapeutic properties, with a specific focus on their applications in respiratory health. Medicinal plants have played a crucial role as a source of ingredients for medications and the synthesis of drugs. Globally, over 35,000 plant species are employed for medicinal purposes, particularly in emerging countries where traditional medicine, predominantly plant-based pharmaceuticals, serves as a primary healthcare resource. This review highlights the significance of medicinal plants, such as aloe, ginger, turmeric, tulsi, and neem, in treating a wide array of common respiratory ailments. These plants contain bioactive compounds, including tannins, alkaloids, sugars, terpenoids, steroids, and flavonoids, which have diverse therapeutic applications. Some medicinal plants, notably

Indexed as

PhytotherapyPlant ExtractsPlants, MedicinalRespiratory Tract DiseasesHumansMedicine, TraditionalPatents as TopicPlant Extractsbioactive extractCOPDMedicinal plantphytochemicalsrespiratory diseases.secondary metabolites

Identifiers

PMID38275072
OpenAlexW4391219655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.